Literature DB >> 14574028

Cardiac resynchronization: a brief synopsis part II: implant and followup methodology.

David M Kalinchak1, Mark H Schoenfeld.   

Abstract

The following sections detail the medical approach of the three implanters within our group from 75 resynchronization implants as well as the technical field support experience from over 300 resynchronization implants.

Mesh：

Year:  2003        PMID： 14574028     DOI： 10.1023/a:1026228322456

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


  14 in total

1.  Inappropriate tachycardia detection by a biventricular implantable cardioverter defibrillator.

Authors:  Emilio Garcia-Moran; Lluís Mont; Josep Brugada
Journal:  Pacing Clin Electrophysiol       Date:  2002-01       Impact factor: 1.976

2.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

3.  Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy.

Authors:  Ole A Breithardt; Christoph Stellbrink; Andrew P Kramer; Anil M Sinha; Andreas Franke; Rodney Salo; Bernhard Schiffgens; Etienne Huvelle; Angelo Auricchio
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

4.  Permanent left ventricular pacing with transvenous leads inserted into the coronary veins.

Authors:  J C Daubert; P Ritter; H Le Breton; D Gras; C Leclercq; A Lazarus; J Mugica; P Mabo; S Cazeau
Journal:  Pacing Clin Electrophysiol       Date:  1998-01       Impact factor: 1.976

5.  Inappropriate shock delivery due to ventricular double detection with a biventricular pacing implantable cardioverter defibrillator.

Authors:  J Schreieck; B Zrenner; C Kolb; G Ndrepepa; C Schmitt
Journal:  Pacing Clin Electrophysiol       Date:  2001-07       Impact factor: 1.976

6.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

7.  Efficacy of biventricular sensing and treatment of ventricular arrhythmias.

Authors:  M Bocchiardo; M Achtelik; F Gaita; H J Trappe; I Lozano; S Higgins; E Daoud; P Yong; C Duby
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

8.  Performance of a new steroid-eluting coronary sinus lead designed for left ventricular pacing.

Authors:  M Achtelik; M Bocchiardo; H J Trappe; F Gaita; I Lozano; I Niazi; M Gold; P Yong; C Duby
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

9.  Initial clinical experience with a new self-retaining left ventricular lead for permanent left ventricular pacing.

Authors:  H F Tse; C Yu; K L Lee; C M Yu; V Tsang; S K Leung; C P Lau
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

10.  Matching approved "nondedicated" hardware to obtain biventricular pacing and defibrillation: feasibility and troubleshooting.

Authors:  Logan Kanagaratnam; Stephen Pavia; Robert Schweikert; Nassir Marrouche; Cathy Lam; Miguel Abreu; Elizabeth Ching; Mina Chung; Walid Saliba; Mark Niebauer; Bruce Wilkoff; Patrick Tchou; Andrea Natale
Journal:  Pacing Clin Electrophysiol       Date:  2002-07       Impact factor: 1.976
View more
  2 in total

Review 1.  Cardiac resynchronization therapy: strategies for device programming, troubleshooting and follow-up.

Authors:  Safwat Gassis; Angel R León
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

2.  Electrocardiographic follow-up of biventricular pacemakers.

Authors:  S Serge Barold; Bengt Herweg; Michael Giudici
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.